Cutaneous presentation of posttransplant lymphoproliferative disorder
- 1 May 2000
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (5) , 923-926
- https://doi.org/10.1016/s0190-9622(00)90273-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disordersBlood, 1995
- PATTERNS OF EPSTEIN-BARR VIRUS LATENT AND REPLICATIVE GENE EXPRESSION IN EPSTEIN-BARR VIRUS B CELL LYMPHOPROLIFERATIVE DISORDERS AFTER ORGAN TRANSPLANTATIONTransplantation, 1994
- Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipientsBlood, 1994
- Clinical characteristics of post-transplant lymphoproliferative disordersThe American Journal of Medicine, 1994
- Posttransplantation Lymphoproliferative DisordersAmerican Journal of Clinical Pathology, 1993
- Posttransplant Lymphoproliferative Disorder Presenting as an Isolated Skin LesionAmerican Journal of Kidney Diseases, 1992
- B-cell lymphoproliferative disorders in solid-organ transplant patients: Detection of Epstein-Barr virus by in situ hybridizationHuman Pathology, 1992
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Five Yearsʼ Experience in Renal Transplantation with Immunosuppressive DrugsAnnals of Surgery, 1968